Highlights for the Quarter Y-O-Y:
- Revenue at ₹2,357 million, a growth of 7%
- Domestic Sales grew by 12%; aided by relaunch
- Export Sales declined by 9%; on a high base
- Profit Before Tax up by 16%
Highlights for the Half Year
- Revenue from Operations at ₹4,649 million, a growth of 18%
- Domestic Sales grew by 14%; aided by relaunch
- Export Sales grew by 27%; on a low base,
- Profit Before Tax up by 25%
MUMBAI | 28th JULY 2026 | Sanofi Consumer Healthcare India Limited (BSE:544250 I NSE: SANOFICONR) releases its financial results for the second quarter and half year ending 2026, demonstrating profitable growth across key business segments. Revenue growth for the quarter stood at 7% year-on-year with Domestic sales growing by 12%, aided by relaunch. Profit Before tax (PBT) for Q2 ‘26 reached ₹919 million, an increase of 16% on a year-on-year basis.
Commenting on the Q2’26 results, Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, said, “Our performance this quarter reflects the disciplined execution on all fronts. Our targeted investments behind our brands and go-to-market capabilities are translating into profitable growth and market share gains in most of our brands, reinforcing our confidence in the strength of our strategy.”
== ENDS ==
